Delivery Order SPE2DR25D3401-SPE2DR26FL0ET
- Not listed
- The Defense Logistics Agency awarded a $35,060.94 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens under a firm fixed-price contract. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation, and performance...
- The Defense Logistics Agency awarded a $6,125.92 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pens on September 15, 2025, with completion targeted for September 16, 2025. This non-competitive delivery order utilizes a firm fixed price structure and represents a small-value pharmaceutical supply transaction. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $16,153.29 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price contract, awarded without a set-aside designation through competitive procurement, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $2,214.84 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 15 mg/0.5 mL pens on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the company's pharmaceutical supply relationship with the federal government. The product will be distributed from AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $2,173.01 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens. The contract, which is a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA, requires delivery by October 22, 2025, to the company's distribution facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a $8,308.62 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 15 mg/0.5 mL pens on December 8, 2025, with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this pharmaceutical supply delivery. The order represents a single transaction under...
- The Defense Logistics Agency awarded a $6,360.82 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections on November 26, 2025, with completion targeted for November 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will...
- The Defense Logistics Agency awarded a delivery order valued at $2,682.27 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pens on September 22, 2025, with completion targeted for September 23, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance...
- The Defense Logistics Agency awarded a $41,950.68 delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 ml pre-filled pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $10,128.30 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pens. This is a firm fixed-price delivery order with a completion date of August 21, 2025, issued under a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL0ETDelivery Order
The Defense Logistics Agency awarded a $6,644.52 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens with a completion date of December 2, 2025. The contract is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of diverse medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. This specific delivery order for Zepbound represents routine fulfillment under that broader contract vehicle and demonstrates AmerisourceBergen's role as a key supplier within the Defense Health Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 11/30/25 |